Clinical Trial Update: Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic interaction study to assess whether rifapentine affects ATRIPLA (efavirenz/emtricitabine/tenofovir disoproxil fumarate) exposure in HIV …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
• rifapentine (rifapentine)

Snippet

Sponsor: Sanofi | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED